A second chance to see: Challenging ophthalmology case offers a path for future treatment

It’s difficult to pinpoint exactly how “Birdie,” a 3-year-old warmblood mare, sustained a micropuncture to her left eye. No matter how pristine a barn may be, and despite the vigilance of owners and trainers, horses encounter an assortment of everyday items that can cause eye trauma — hay and straw, dust and debris, tree branches or the bristle-like tips on pasture grasses being among the most common.

What Birdie’s care team at the Auburn University College of Veterinary Medicine can attest to with certainty is that she was at risk of permanently losing vision in her left eye when she made the trip from Tennessee to the J.T. Vaughan Large Animal Teaching Hospital in September for treatment. A small wound quickly deteriorated into a severe corneal infection and inflammation that made enucleation (surgical removal of the eye) a potential outcome.

Birdie and care team
Drs. Meredith Voyles, Emma Collins, Milena Sanchez-Garcia and Anna Catherine Bowden visit with Birdie, a 3-year-old warmblood mare, before she returned home to Tennessee in late October.

“It did not look great,” said Dr. Anna Catherine Bowden, assistant professor of veterinary ophthalmology. “Dr. (Emma) Collins and I were researching implant options for her to try to get something cosmetic.

“She had a very poor prognosis for keeping her eye or regaining any vision, but her owner was determined to do everything she could for Birdie.”

And Auburn’s ophthalmology service team was determined to provide the best possible care — including an approach that may guide the future treatment of horses facing similar challenges.

A race to save Birdie’s eye

When Birdie returned home to Nashville in late October, her left eye was intact, and she had regained a portion of her vision. The six weeks leading to that outcome were filled with uncertainty, however.

Auburn Vet Med’s ophthalmology service treats a variety of eye disorders in small and large animals, including glaucoma, tumors, retinal diseases and cataracts. For equine patients like Birdie, micropunctures and resulting fungal infections represent a common reason for a referral to Auburn. Bowden said the team typically sees multiple cases per month and, during heavy periods, multiple cases per week.

“Unfortunately, fungal infections are particularly difficult to treat,” Bowden said. “We see them more frequently in the Southeast due to the environmental heat and humidity.”

Because corneal abscesses can start with a tiny wound, horse owners should contact their veterinarian if they notice redness to the eye, tearing, squinting, color change to the clear part of the eye (blue or yellow) or being “head shy” on a specific side.

The size and scope of Birdie’s infection and inflammation necessitated a multi-pronged approach to treatment. Equine ophthalmologists sometimes refer to “multifactorial” cases because they may be trying to head off several destructive processes occurring simultaneously. Fungi can penetrate deep into the cornea, where it may be difficult for topical medications to reach. Plus, no single antifungal works against every fungal species.

“We took a multi-modal approach and treated it very aggressively,” said Dr. Emma Collins, an ophthalmology resident.

As Associate Clinical Professor Dr. Meredith Voyles explained, Birdie’s treatment plan included multiple corneal injections of antibiotics and two different antifungal medications. The injections delivered medication to the precise site of the infection and are integral in the treatment of stomal abscess cases.

Bowden said the corneal injections were paired with subconjunctival injections (beneath the pink tissue of the eye) of antimicrobials and atropine, which helps reduce inflammation. They also utilized oral medications and a Subpalpebral Lavage System (SPL), a catheter installed beneath the upper eyelid that serves as an IV line for the eye and allowed Birdie to receive time-released medication.

Offering a vision for future case treatments

As Birdie awaited the arrival of her trainer on the morning of Oct. 30, Bowden, Voyles, Collins and ophthalmology resident Dr. Milena Sanchez-Garcia marveled over her progress and improved outlook. An animal once in danger of losing an eye might still be able to continue training as a hunter-jumper.

The improved prognosis may stem, in part, from the application of lessons learned by the ophthalmology service team in the past year. After several cases in which the ophthalmology team noticed a lack of response to voriconazole, a broad-based and commonly used antifungal, it began utilizing Amphotericin B as an injection treatment.

“This made us concerned about fungal resistance – a scary prospect in the Southeast,” Bowden said. “We started augmenting difficult fungal infections with Amphotericin B and have had good success, particularly in cases where they are not responding as we would like.”

Bowden said Amphotericin B has rarely been utilized in equine ophthalmology because other antifungals were more thoroughly studied and readily available. However, the Auburn clinicians have found it to be a “safe, comfortable and successful medication when injected into the cornea or applied topically on the surface of the eye.”

Auburn’s clinicians have presented their findings to national and international audiences and are working on a manuscript for publication.

More than six weeks ago, Birdie’s future as a show horse was uncertain. A tiny injury had evolved into a sight-threatening infection, and her care team couldn’t promise she would keep her eye.

Today, she still has it. Her recovery speaks to the determination of her owner and a reminder of what can happen when advanced specialty care, innovative treatment strategies and persistence converge.

Equine Vaughan Large Animal Teaching Hospital